Roberto Serna‐Blasco

Perioperative Nivolumab and Chemotherapy in Stage III Non–Small-Cell Lung Cancer

Mariano Provencio, Ernest Nadal, J.L. González-Larriba et al. · New England Journal of Medicine · 2023 · 397 citations · Full text

Overall Survival and Biomarker Analysis of Neoadjuvant Nivolumab Plus Chemotherapy in Operable Stage IIIA Non–Small-Cell Lung Cancer (NADIM phase II trial)

Mariano Provencio, Roberto Serna‐Blasco, Ernest Nadal et al. · Journal of Clinical Oncology · 2022 · 322 citations · Full text

Vitamin C activates pyruvate dehydrogenase (PDH) targeting the mitochondrial tricarboxylic acid (TCA) cycle in hypoxic <i>KRAS</i> mutant colon cancer

Aiora Cenigaonandia‐Campillo, Roberto Serna‐Blasco, Laura Gómez-Ocabo et al. · Theranostics · 2021 · 54 citations · Full text

Tumor microenvironment gene expression profiles associated to complete pathological response and disease progression in resectable NSCLC patients treated with neoadjuvant chemoimmunotherapy

Marta Casarrubios, Mariano Provencio, Ernest Nadal et al. · Journal for ImmunoTherapy of Cancer · 2022 · 54 citations · Full text

Perioperative chemotherapy and nivolumab in non-small-cell lung cancer (NADIM): 5-year clinical outcomes from a multicentre, single-arm, phase 2 trial

Mariano Provencio, Ernest Nadal, Amelia Insa et al. · The Lancet Oncology · 2024 · 51 citations · Full text

Non-small-cell Lung Cancer, Medicine, Metronomic Therapy +8